Breaking News, Promotions & Moves

Levicept Names Eliot Forster CEO

Forster brings more than thirty years of experience in the biotech and pharmaceutical sectors.

Levicept Ltd., a biotechnology company focused on the development of LEVI-04, a treatment for chronic pain indications, appointed Eliot Forster CEO. Founder and inventor of LEVI-04, Simon Westbrook, has been named chief science officer (CSO). Forster brings more than thirty years of experience in the biotech and pharmaceutical sectors, with experience in deal making and finance. The appointment strengthens the Levicept leadership team as the company matures through clinical development of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters